Annual Accounts Payable
$806.00 K
-$2.16 M-72.82%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual accounts payable is $806.00 thousand, with the most recent change of -$2.16 million (-72.82%) on December 31, 2023.
- During the last 3 years, ATOS annual accounts payable has fallen by -$783.00 thousand (-49.28%).
- ATOS annual accounts payable is now -72.82% below its all-time high of $2.96 million, reached on December 31, 2022.
Performance
ATOS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.56 M
+$505.00 K+47.82%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly accounts payable is $1.56 million, with the most recent change of +$505.00 thousand (+47.82%) on September 30, 2024.
- Over the past year, ATOS quarterly accounts payable has increased by +$843.00 thousand (+117.41%).
- ATOS quarterly accounts payable is now -47.35% below its all-time high of $2.96 million, reached on December 31, 2022.
Performance
ATOS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ATOS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.8% | +117.4% |
| 3 y3 years | -49.3% | +133.7% |
| 5 y5 years | +128.1% | +133.7% |
ATOS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.8% | at low | -47.4% | +117.4% |
| 5 y | 5-year | -72.8% | +174.9% | -47.4% | +432.4% |
| alltime | all time | -72.8% | -100.0% | -47.4% | -100.0% |
Atossa Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.56 M(+47.8%) |
| Jun 2024 | - | $1.06 M(-14.1%) |
| Mar 2024 | - | $1.23 M(+52.6%) |
| Dec 2023 | $806.00 K(-72.8%) | $806.00 K(+12.3%) |
| Sep 2023 | - | $718.00 K(-38.8%) |
| Jun 2023 | - | $1.17 M(-18.7%) |
| Mar 2023 | - | $1.44 M(-51.3%) |
| Dec 2022 | $2.96 M(+72.7%) | $2.96 M(+79.4%) |
| Sep 2022 | - | $1.65 M(-19.4%) |
| Jun 2022 | - | $2.05 M(+28.6%) |
| Mar 2022 | - | $1.60 M(-7.0%) |
| Dec 2021 | $1.72 M(+8.1%) | $1.72 M(+157.0%) |
| Sep 2021 | - | $668.00 K(+24.2%) |
| Jun 2021 | - | $537.90 K(-25.5%) |
| Mar 2021 | - | $722.30 K(-54.5%) |
| Dec 2020 | $1.59 M(+442.0%) | $1.59 M(+132.8%) |
| Sep 2020 | - | $682.60 K(-33.9%) |
| Jun 2020 | - | $1.03 M(+189.8%) |
| Mar 2020 | - | $356.30 K(+21.5%) |
| Dec 2019 | $293.20 K(-17.0%) | $293.20 K(-41.5%) |
| Sep 2019 | - | $501.40 K(+57.5%) |
| Jun 2019 | - | $318.30 K(-31.4%) |
| Mar 2019 | - | $464.00 K(+31.3%) |
| Dec 2018 | $353.30 K | $353.30 K(-35.8%) |
| Sep 2018 | - | $550.70 K(+188.0%) |
| Jun 2018 | - | $191.20 K(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $168.30 K(-49.7%) |
| Dec 2017 | $334.90 K(+31.7%) | $334.90 K(-12.0%) |
| Sep 2017 | - | $380.40 K(-23.3%) |
| Jun 2017 | - | $495.80 K(+28.1%) |
| Mar 2017 | - | $386.90 K(+52.1%) |
| Dec 2016 | $254.30 K(-68.8%) | $254.30 K(+28.8%) |
| Sep 2016 | - | $197.40 K(-30.2%) |
| Jun 2016 | - | $282.80 K(-34.1%) |
| Mar 2016 | - | $429.10 K(-47.3%) |
| Dec 2015 | $814.40 K(+58.8%) | $814.40 K(-30.9%) |
| Sep 2015 | - | $1.18 M(+103.2%) |
| Jun 2015 | - | $580.50 K(-39.9%) |
| Mar 2015 | - | $966.20 K(+88.3%) |
| Dec 2014 | $513.00 K(+106.8%) | $513.00 K(+16.8%) |
| Sep 2014 | - | $439.20 K(-44.4%) |
| Jun 2014 | - | $790.20 K(>+9900.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $248.10 K(+263.8%) | $248.10 K(+697.7%) |
| Sep 2013 | - | $31.10 K(-83.1%) |
| Jun 2013 | - | $184.00 K(+431.8%) |
| Mar 2013 | - | $34.60 K(-49.3%) |
| Dec 2012 | $68.20 K(+5.2%) | $68.20 K(-5.4%) |
| Sep 2012 | - | $72.10 K(+0.8%) |
| Jun 2012 | - | $71.50 K(-26.1%) |
| Mar 2012 | - | $96.70 K(+49.2%) |
| Dec 2011 | $64.80 K(>+9900.0%) | $64.80 K(>+9900.0%) |
| Dec 2010 | $0.00 | $0.00 |
FAQ
- What is Atossa Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Atossa Therapeutics?
- What is Atossa Therapeutics annual accounts payable year-on-year change?
- What is Atossa Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly accounts payable year-on-year change?
What is Atossa Therapeutics annual accounts payable?
The current annual accounts payable of ATOS is $806.00 K
What is the all time high annual accounts payable for Atossa Therapeutics?
Atossa Therapeutics all-time high annual accounts payable is $2.96 M
What is Atossa Therapeutics annual accounts payable year-on-year change?
Over the past year, ATOS annual accounts payable has changed by -$2.16 M (-72.82%)
What is Atossa Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ATOS is $1.56 M
What is the all time high quarterly accounts payable for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly accounts payable is $2.96 M
What is Atossa Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ATOS quarterly accounts payable has changed by +$843.00 K (+117.41%)